file

Pretest self-assessment question (answer at the end of the case)


Which of the following is true regarding QTc prolongation and antipsychotics?




A. Thioridazine (Mellaril) has a warning



B. Ziprasidone (Geodon) has a warning



C. Iloperidone (Fanapt) has a warning



D. Electrocardiogram (EKG) monitoring should occur in cardiac risk patients, or those on antipsychotic polypharmacy, or those on super-dosed monotherapies



E. Only the antipsychotics in A, B, C should have EKG monitoring



F. All antipsychotics should have EKG monitoring



G. B and C



H. A, B, C, and D






Patient evaluation on intake




  • 42-year-old man with a chief complaint of depression and family stress



Psychiatric history




  • Was doing well until he became stressed with household issues and family issues



  • Remains gainfully employed as an assembly line worker despite his stress



  • When seen by a previous provider, was diagnosed with minor depression/adjustment disorder and placed on a minimal dose trial of an SSRI



  • Goes to weekly supportive psychotherapy



  • His psychiatrist moved and he presented for admission with minor depressive symptoms as noted



  • However, this initial psychiatric interview revealed poor sleep, irritable and low mood, poor concentration, affect constriction, loss of speech prosody, and concrete thoughts



  • Furthermore, when asked about psychotic symptoms, the patient nonchalantly stated that he did in fact receive messages from the TV, radio, and the assembly line at work. He admitted to “picking things up” all the time



  • Outside picking up messages from the TV




    • If a car drove by, he could hear people talking in the car even if they were miles away



    • He would also pick up images in mirrors



    • These took the form of hallucinations with which he has interacted



    • The messages he received from these were mostly neutral and not affective laden, although some are derogatory



    • These have been present for at least a year



    • He is not distressed over these occurrences



  • Currently takes only an SSRI from the previous provider




    • Sertraline (Zoloft) 50 mg/d



  • No other previous medication trials



  • No psychiatric admission history



  • No suicide attempts



Social and personal history




  • Married and has four adult children



  • High school educated and is working full time



  • Has a supportive wife, but they have had difficulties in the past



  • Does not drink alcohol, smoke cigarettes, or abuse drugs



  • There are no legal issues and he gets along well in the community and at work



Medical history




  • There are no acute and no chronic medical problems



  • Normal with regard to height, weight, and vitals



  • There are no abnormal movements



Family history




  • MDD in mother



  • SUD throughout extended family



  • ADHD in grandson



Current psychiatric medications




  • Sertraline (Zoloft) 50 mg/d (SSRI)



Current medical medications




  • None



Question


Based on this patient’s history and the available evidence, what do you consider his diagnosis to be?




  • MDD with psychotic features



  • Adjustment disorder



  • Schizophrenia



  • Schizoaffective disorder



  • Schizotypal personality


What would your next treatment likely be?




  • Increase the SSRI, as sometimes this alleviates depressive psychosis



  • Add an atypical antipsychotic



  • Switch to an atypical antipsychotic



  • Better delineate his diagnosis



  • Refer for CBT or family therapy



Attending physician’s mental notes: initial evaluation




  • This patient is psychotic, which was apparently missed by the previous providers



  • He is not guarded. Perhaps this was missed as he appears normal to most people, has a family, is gainfully employed, is older, and does not “look schizophrenic”



  • Perhaps these symptoms have started in last few months and these did not exist when he started treatment with the prior provider



  • Perhaps these symptoms have been present for several years regardless of his stress and depression levels and he has learned to live with them



  • His depression is mild at best and does not appear severe enough to fuel psychotic symptoms



  • Will need to see if he is psychotic even when fully euthymic, which suggests the differential diagnosis of schizoaffective disorder versus schizophrenia



  • Will need to rule out substance-induced psychosis, although his history suggests no drug abuse



  • Will need to rule out medically induced psychosis as he is a bit older with regard to developing schizophrenia



Further investigation


Is there anything else you would especially like to know about this patient?




  • His history does need further clarification




    • Family members eventually present with the patient and confirm his history




      • They have seen the patient stressed and depressed but never to the degree where he missed work



      • They have not witnessed overt psychotic behavior where he has been seen interacting with his hallucinations (although he was moved from one assembly line to another the previous year). Patient confirms he asked to move as the hallucinations were distracting



      • They deny that he abuses drugs or alcohol



      • They deny any previous family history consistent with an SPMI



      • The family reports that the patient has been more concrete and less emotional over the years. His loss of facial expression and bland speech has been felt to be due to depression. The patient does not see himself as depressed



      • The patient states that he has had these hallucinations for some time but has not recognized them as foreign. They occur regardless of mood



      • Medical workup shows no laboratory test abnormalities and his physical and neurological examination is normal



Question


Based on what you know about this patient’s history and current symptoms, what would you do now?




  • Increase the SSRI as sometimes this alleviates depressive psychosis



  • Add an atypical antipsychotic



  • Switch to an atypical antipsychotic



  • Better delineate his diagnosis



  • Order neuroimaging such as a brain MRI or computerized tomography (CT)



  • Order an electroencephalogram (EEG)



  • Order psychological testing



  • Refer for CBT or family therapy



Attending physician’s mental notes: initial evaluation (continued)




  • The patient is consistently psychotic now. He has negative symptoms that were prodromal, and this appears to be late-onset schizophrenia



  • Medical workup is negative



  • He should have brain imaging to prove he has no mass lesion, given the late-age onset of symptoms



  • There are no neurological changes, confusion, altered states of consciousness (delirium), and no seizure activity, thus an EEG is not warranted



  • He is clearly psychotic; therefore, psychological testing is not warranted



Case outcome: interim follow-ups through six months




  • The patient is started and titrated slowly onto risperidone (Risperdal) without issue, and is left on 4 mg/d for several weeks



  • This is partially effective in treating his positive symptoms. Dose is escalated to 6 mg/d



  • The hallucinations resolve and the mild negative symptoms continue. He continues to work without any issues



  • Toward the end of this period, his ideas of reference (IOR) begin to return




    • Higher dosing (8 mg/d) causes mild parkinsonism-like extrapyramidal symptoms, noted as resting tremor in one arm/hand



  • Next he is switched to the only other atypical antipsychotic, olanzapine (Zyprexa), available at the time and is titrated to the recommended 10 mg/d, which alleviates his psychosis



  • Psychosis returns after several more weeks




    • The atypical antipsychotic is increased to the maximum approved dose of 20 mg/d with resolution of the positive symptoms



  • Again psychosis returns; olanzapine (Zyprexa) is increased above the approved norm to 30 mg/d




    • Positive symptoms resolve. He remains psychosis free for many months and continues to work



    • 15 lbs of AAWG occurs and there is a recurrence of mild parkinsonism. He tolerates both of these side effects without immediate concern



  • Brain MRI is negative


Considering his current medication side effects, do you have any concerns?




  • The weight gain might coexist with a metabolic disorder and laboratory samples should be sent for analysis



  • The EPS is mild and tolerated, but he should be offered antiparkinsonian medication



  • This early EPS is a poor prognostic indicator and TD is more likely to develop



  • Need to make sure to monitor EPS closely and frequently



  • Given the difficulty managing his psychosis and his initial propensity to side effects, a referral for family therapy may be warranted to keep his stress levels and expressed emotion levels in the home low



Attending physician’s mental notes: six months




  • At the time of this treatment, metabolic disorder was not well understood or appreciated, guidelines did not exist, and laboratory blood samples were not drawn for monitoring very often



  • Initially, this patient looked easy to treat as his initial atypical antipsychotic was effective at usual dosing guidelines



  • Now, he is looking more treatment resistant as his second atypical antipsychotic is requiring very high doses to alleviate his psychosis



  • Olanzapine (Zyprexa) was approved at doses up to 20 mg/d




    • The use of 30 mg/d is off-label



    • There is little available data to support this practice but he is responding



    • Theoretically, his dose must now be blocking enough D2 receptors to provide antipsychotic effects



  • What were the causes of his relapses on risperidone (Risperdal) and lower dose olanzapine (Zyprexa)?




    • Treatment resistance and his more severe illness



    • An artifact of switching his medications and a window of undertreated psychosis during the cross-titration when both atypical antipsychotic doses were relatively low



  • He is being very compliant despite weight gain and EPS side effects



  • Will need to convince him to stay on his medications over the long term to avoid a worsening prognosis and social downward drift



Case outcome: interim follow-ups through nine months




  • EPS are easy to monitor and to treat




    • Patient is offered benztropine (Cogentin) 1 mg/d to control his EPS and this was effective without any burdensome anticholinergic side effects



Case outcome: interim follow-ups through 18 months




  • Continues to see his supportive psychotherapist, who also intervenes more with family in sessions aimed at decreasing household stress and high expressed emotions



  • Olanzapine (Zyprexa) 30 mg/d is continued




    • At the time of this treatment, metabolic disorder was not well understood, guidelines were not available, and laboratory blood samples were not analyzed, but his weight was followed sequentially. His weight gain did not progress past 15 lbs



  • He continued to do well with only mild negative symptoms



Attending physician’s mental notes: through 20 months




  • Patient is doing very well



  • Have to continue his simple medication regimen as long as possible



  • It appears we began treatment in his first psychotic break



  • His prognosis is promising



Question


How long should you treat this patient with his antipsychotic?




  • After remission of psychosis, treat one year and then discontinue



  • After remission of psychosis, treat five years and then discontinue



  • After remission of psychosis, treat 10 years and then discontinue



  • After remission of psychosis, treat indefinitely as only 10% of schizophrenics go on to maintain remission without medications and to lead relatively normal lives



  • After remission of psychosis, treat indefinitely unless side effects complicate ongoing treatment



Case outcome: interim follow-ups through 24 months




  • The patient gradually presents with difficulties




    • Increased stress due to issues with his family



    • Now has insomnia



    • He is not depressed, nor suicidal



    • Starts to have problems at work, which require intervention and moving to yet another assembly line



    • In session, he admits his psychosis is back to a moderate level. His hallucinations are mostly neutral but more now have negative and critical content



    • Mild IOR are back and they may be delusional, as he feels a local company’s work trucks are following him around (this regional company has thousands of service trucks randomly around at any given time)



Question


What would you do now?




  • Superdose the olanzapine (Zyprexa) up to 40 mg/d to recapture efficacy



  • Add a typical antipsychotic as a combination therapy



  • Switch to a new atypical antipsychotic



  • Switch to a typical antipsychotic monotherapy



Attending physician’s mental notes: 24-month follow-ups




  • Life stress likely has caused his recurrence



  • Need to make sure psychotherapy is in place and need to discuss with his work how to keep him employed without losing his job. Consider disability



  • 40 mg/d of olanzapine (Zyprexa) seems high, but he did very well for many months on the 30 mg/d dose, and could temporarily use a higher dose until psychosis subsides



  • Switching to the other, then currently available, a typical antipsychotic, quetiapine (Seroquel), is possible, but the cross-titration and its lower affinity may allow for more breakthrough psychosis to evolve



  • Clozapine (Clozaril) is an option but perhaps his schizophrenia is not sufficiently resistant yet to require clozapine and its excessive side-effect burden


Does psychotherapy treat schizophrenia?




  • The patient is getting supportive, intermittent family interventions but not formal family therapy in an ongoing manner. This type of therapy has an evidence base for treating schizophrenia



  • CBT also has data to support its use in schizophrenia, more so for improving cognition and executive functioning



  • Unfortunately, he likely needs more medication to lower his positive symptoms over the acute period to save his job in the short term

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 16, 2017 | Posted by in PHARMACY | Comments Off on file

Full access? Get Clinical Tree

Get Clinical Tree app for offline access